Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Glaucoma
How does a history of malignant glaucoma in one eye influence your surgical approach to the fellow eye, particularly regarding prophylactic/intra-operative measures (i.e., iridotomy, IZH)?
Related Questions
What’s your threshold for initiating treatment in patients with optic nerve cupping but normal IOP, normal visual fields, and borderline OCT findings?
How do you determine the optimal timing for surgery in patients with uveitic glaucoma?
How do you adjust your glaucoma management strategy for pregnant patients who require IOP lowering?
What has been your experience with Durysta (bimatoprost implant) for glaucoma management?
What is your approach to managing failed trabeculectomies with scarring but controlled IOP?
What are the clinical indications for performing a second laser peripheral iridotomy (LPI) instead of proceeding directly with cataract surgery?
How would you approach choosing a MIGS procedure for a patient with mild glaucoma with progressively worsening PAS undergoing cataract surgery?
For patients with neovascular glaucoma and uncontrolled IOP, do you ever consider a glaucoma drainage device (GDD) combined with ECP as opposed to just a standalone GDD?
How do you manage cystoid macular edema (CME) in patients with steroid-induced intraocular hypertension that is resistant to topical treatments?
How do you decide between escalating treatment with additional IOP-lowering medications versus surgical options for patients with normal tension glaucoma and progressive visual field loss despite well-controlled IOP?
